Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL405759

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1

Basic Information

ChEMBL ID CHEMBL405759
Phase Preclinical
Structure Type MOL
InChI Key VPVLEBIVXZSOMQ-UHFFFAOYSA-N
4
Targets
10
Activities
3
Assay Types
0
PK Parameters
20
Publications
0
Known Names

Molecular Properties

318.3
MW (Da)
3.71
ALogP
5
HBA
3
HBD
97.0
PSA (Ų)
0.50
QED
0
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C18H14N4O2
MW 318.34
Aromatic Rings 4
Heavy Atoms 24
NP-Likeness -0.47

Activity Summary

IC50 6 meas. best 7.52
EC50 3 meas. best 6.0
Kd 1 meas. best 6.9

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Glycogen synthase kinase-3 beta
CHEMBL1075321
IC50 7.52 7.52 30.0 1
Glycogen synthase kinase-3 beta
CHEMBL262
IC50 7.52 7.52 30.0 3
Glycogen synthase kinase-3 beta
CHEMBL1075321
Kd 6.9 6.9 126.0 1
Glycogen synthase kinase-3 beta
CHEMBL1075321
EC50 6.0 6.0 1000.0 3
Interferon-induced, double-stranded RNA-activated protein kinase
CHEMBL5785
IC50 5.4 5.4 4000.0 1
Myc proto-oncogene protein/Transcription factor AP-1
CHEMBL3885607
IC50 4.82 4.82 15000.0 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
16408003 10.1038/nchembio0705-74 Glycogen synthase kinase-3 beta 5
23398362 10.1042/bj20121418 Insulin-like growth factor 1 receptor 4
23398362 10.1042/bj20121418 Insulin receptor 4
23398362 10.1042/bj20121418 Cyclin-dependent kinase 5/CDK5 activator 1 4
23398362 10.1042/bj20121418 Tyrosine-protein kinase HCK 4
23398362 10.1042/bj20121418 cGMP-dependent protein kinase 1 4
- 10.6019/CHEMBL4495565 SARS-CoV-2 4
23398362 10.1042/bj20121418 Serine/threonine-protein kinase mTOR 4
23398362 10.1042/bj20121418 Tyrosine-protein kinase Lck 4
23398362 10.1042/bj20121418 Protein kinase C beta type 4
23398362 10.1042/bj20121418 Tyrosine-protein kinase ABL2 2
23398362 10.1042/bj20121418 Inhibitor of nuclear factor kappa-B kinase subunit alpha 2
23398362 10.1042/bj20121418 Death-associated protein kinase 1 2
23398362 10.1042/bj20121418 Calcium/calmodulin-dependent protein kinase type 1D 2
23398362 10.1042/bj20121418 Casein kinase I isoform gamma-3 2
23398362 10.1042/bj20121418 Cyclin-dependent kinase 2/cyclin A 2
23398362 10.1042/bj20121418 Aurora kinase A 2
23398362 10.1042/bj20121418 Serine/threonine-protein kinase Nek7 2
23398362 10.1042/bj20121418 Serine/threonine-protein kinase MARK1 2
23398362 10.1042/bj20121418 Cyclin-dependent kinase 2/cyclin E 2

Data from ChEMBL 36 via Core Engine